283 related articles for article (PubMed ID: 19446662)
1. Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets.
Giuliani N; Mangoni M; Rizzoli V
Exp Hematol; 2009 Aug; 37(8):879-86. PubMed ID: 19446662
[TBL] [Abstract][Full Text] [Related]
2. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow.
Gregory CA; Gunn WG; Reyes E; Smolarz AJ; Munoz J; Spees JL; Prockop DJ
Ann N Y Acad Sci; 2005 May; 1049():97-106. PubMed ID: 15965110
[TBL] [Abstract][Full Text] [Related]
3. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis.
Dalle Carbonare L; Valenti MT; Zanatta M; Donatelli L; Lo Cascio V
Arthritis Rheum; 2009 Nov; 60(11):3356-65. PubMed ID: 19877060
[TBL] [Abstract][Full Text] [Related]
4. Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells.
Cho SW; Yang JY; Sun HJ; Jung JY; Her SJ; Cho HY; Choi HJ; Kim SW; Kim SY; Shin CS
Bone; 2009 Jun; 44(6):1069-77. PubMed ID: 19254785
[TBL] [Abstract][Full Text] [Related]
5. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
6. Murine osteoblasts regulate mesenchymal stem cells via WNT and cadherin pathways: mechanism depends on cell-cell contact mode.
Wang Y; Volloch V; Pindrus MA; Blasioli DJ; Chen J; Kaplan DL
J Tissue Eng Regen Med; 2007; 1(1):39-50. PubMed ID: 18038391
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
[TBL] [Abstract][Full Text] [Related]
8. [Bone disease in multiple myeloma and its mechanism].
Abe M
Clin Calcium; 2006 Apr; 16(4):565- 71. PubMed ID: 16582506
[TBL] [Abstract][Full Text] [Related]
9. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.
Gunn WG; Conley A; Deininger L; Olson SD; Prockop DJ; Gregory CA
Stem Cells; 2006 Apr; 24(4):986-91. PubMed ID: 16293576
[TBL] [Abstract][Full Text] [Related]
10. Dickkopf-1: a suitable target for the management of myeloma bone disease.
Gavriatopoulou M; Dimopoulos MA; Christoulas D; Migkou M; Iakovaki M; Gkotzamanidou M; Terpos E
Expert Opin Ther Targets; 2009 Jul; 13(7):839-48. PubMed ID: 19530987
[TBL] [Abstract][Full Text] [Related]
11. Role of osteoblast suppression in multiple myeloma.
Stewart JP; Shaughnessy JD
J Cell Biochem; 2006 May; 98(1):1-13. PubMed ID: 16440324
[TBL] [Abstract][Full Text] [Related]
12. Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells.
Plaisant M; Fontaine C; Cousin W; Rochet N; Dani C; Peraldi P
Stem Cells; 2009 Mar; 27(3):703-13. PubMed ID: 19096040
[TBL] [Abstract][Full Text] [Related]
13. Wnt and BMP signaling pathways co-operatively induce the differentiation of multiple myeloma mesenchymal stem cells into osteoblasts by upregulating EMX2.
Wei XF; Chen QL; Fu Y; Zhang QK
J Cell Biochem; 2019 Apr; 120(4):6515-6527. PubMed ID: 30450775
[TBL] [Abstract][Full Text] [Related]
14. New potential targets for treating myeloma bone disease.
Roodman GD
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6270s-6273s. PubMed ID: 17062712
[TBL] [Abstract][Full Text] [Related]
15. Cbfb enhances the osteogenic differentiation of both human and mouse mesenchymal stem cells induced by Cbfa-1 via reducing its ubiquitination-mediated degradation.
Lien CY; Lee OK; Su Y
Stem Cells; 2007 Jun; 25(6):1462-8. PubMed ID: 17379770
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms for formation of myeloma bone disease].
Yata K; Abe M; Matsumoto T
Clin Calcium; 2008 Apr; 18(4):438-46. PubMed ID: 18379024
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic properties of human myogenic progenitor cells.
Hashimoto N; Kiyono T; Wada MR; Umeda R; Goto Y; Nonaka I; Shimizu S; Yasumoto S; Inagawa-Ogashiwa M
Mech Dev; 2008; 125(3-4):257-69. PubMed ID: 18164186
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells.
Silvestris F; Cafforio P; De Matteo M; Calvani N; Frassanito MA; Dammacco F
Clin Cancer Res; 2008 Oct; 14(19):6081-91. PubMed ID: 18829486
[TBL] [Abstract][Full Text] [Related]
19. ICAT participates in proliferation and osteogenic differentiation of human adipose tissue-derived mesenchymal stem cell.
Kim YJ; Kim JT; Bae YC; Suh KT; Jung JS
Life Sci; 2008 Dec; 83(25-26):851-8. PubMed ID: 18977368
[TBL] [Abstract][Full Text] [Related]
20. Stem cell regulatory gene expression in human adult dental pulp and periodontal ligament cells undergoing odontogenic/osteogenic differentiation.
Liu L; Ling J; Wei X; Wu L; Xiao Y
J Endod; 2009 Oct; 35(10):1368-76. PubMed ID: 19801232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
